ライフサイエンスコーパス: mixed-type

1 nal groups (i.e., hydroxamate, catechol, and mixed type).

2 -2 and TG, the inhibition appeared to be the mixed type.

3 eyes (14.3%) as type 2, and 1 eye (7.1%) as mixed type.

4 , and one met criteria for bipolar disorder, mixed type.

5 e and less frequently of the cholestatic and mixed types.

6 given SBR alone, and these cells displayed a mixed type 1 and 2 (or Th0) pattern of cytokine expressi

7 eumonic plague vaccines should aim to induce mixed type 1 and type 17 cellular responses.

8 made as part of a type 0 cytokine response (mixed type 1 and type 2) and is required for normal deve

9 ogic subtypes: type 1, low-grade type 2, and mixed type 1/low-grade type 2 tumors.

10 es and were mediated by T cells displaying a mixed type 1/type 2 cytokine phenotype.

11 , whereas IL-10-deficient animals generate a mixed type 1/type 2 cytokine profile and show reduced pu

12 A mixed type 1/type 2 response of IFN-gamma-producing CD8(

13 imaging, 74 patients had MD-IPMN (14%), 205 mixed-type (40%), and 233 suspected BD-IPMN (46%).

14 s 3.7 months, with the majority of IHs being mixed type (57%) affecting the head and neck (81%).

15 ease in the Vmax for phosphate, indicating a mixed type activation.

16 step, while glutamine provided nonessential mixed-type activation of the uridylyl-removing activity,

17 vided into four categories: fibrosis, pearl, mixed type and late-postoperative capsular bag distensio

18 analyses showed that cryptotanshinone was a mixed-type and irreversible inhibitor.

19 24 (35%) were surgical, and 20 (29%) were of mixed type, and 64 (93%) were located in teaching hospit

20 f MMP-7, MMP-9, and MT1-MMP by Brij-35 was a mixed type as determined by Dixon's plot; however, the i

21 mpounds indicated that majority of them were mixed-type BChE inhibitors.

22 A Lineweaver-Burk plot indicates mixed-type competitive ligand binding between VPg and an

23 sis for wild type and mutant protease showed mixed-type competitive-uncompetitive inhibition for daru

24 were analyzed in 53 patients (33 cam- and 20 mixed-type FAI) and 53 age- and sex-matched asymptomatic

25 tial equations including elliptic-hyperbolic mixed type, free-boundary problems, and corner singulari

26 ntidiabetic agents that act as nonessential, mixed-type GK activators (GKAs) that increase the glucos

27 lso induces antiparallel structure to form a mixed-type hybrid structure in Na(+) solution.

28 ocnemius and tibialis anterior muscles (with mixed type I and II fiber content), while a significant

29 ) were single-type infections, 9 (8.0%) were mixed-type infections with more than one G or P type, an

30 ver-Burk plots indicated that 5-CQA exerts a mixed type inhibition as km increased and Vmax decreased

31 Troglitazone exhibited a mixed type inhibition of ACS4.

32 analogues 3-OPP/OPP and 3-SPP/SPP displayed mixed type inhibition with KI = 1.4 muM and KI = 5.5 muM

33 rs were in the range of 0.5-56 muM, all with mixed type inhibition, predominantly competitive.

34 The model suggests a mixed-type inhibition mechanism for Mg(2+) inhibition of

35 075 and 0.10 mM, respectively, and showing a mixed-type inhibition mode.

36 complex, ISIS 2302 demonstrated hyperbolic, mixed-type inhibition of chromogenic substrate cleavage

37 ISIS 2302 demonstrated hyperbolic, mixed-type inhibition of factor X activation by the intr

38 tes acted as a random bireactant system with mixed-type inhibition of substrate binding by one substr

39 how that SLO-1 proceeds through a hyperbolic mixed-type inhibition pathway, where OS binding (K(i) =

40 ifluoromethylphenyl)acetamide (5), showed a mixed-type inhibition pattern, with a K(i) of 1.3 muM an

41 The compound exhibits mixed-type inhibition with respect to all three enzyme s

42 mechanism analogous to system C5 hyperbolic mixed-type inhibition with respect to erythrose-4-phosph

43 f factor IX activation was best described by mixed-type inhibition with the affinity of leupeptin and

44 ate larger inhibitory complexes resulting in mixed-type inhibition, in the presence of selenate and p

45 4 +/- 32 nM) was characterized by hyperbolic mixed-type inhibition, indicating that factor IX binds t

46 ia PfCRT in a manner that is consistent with mixed-type inhibition.

47 (0.075+/-0.010-0.103+/-0.017) mg/ml, also a mixed-type inhibition.

48 petitive substrate inhibition and by GTP via mixed-type inhibition.

49 0.81+/-0.03mg/ml, respectively; both showed mixed-type inhibition.

50 ults suggested that the inhibitor acted as a mixed type inhibitor by reducing both anodic and cathodi

51 CG was a competitive inhibitor of FabI and a mixed type inhibitor of FabG demonstrating that EGCG int

52 or versus ATP, whereas quercetin serves as a mixed type inhibitor versus ATP.

53 lyzed cleavage of allothreonine as a partial mixed type inhibitor, reducing both k(cat) and K(m) by 4

54 o IRF3 phosphorylation, SIKE functioned as a mixed-type inhibitor (K(i, app) = 350 nM) rather than, g

55 tudies showed that 10-thiastearoyl-ACP was a mixed-type inhibitor of 18:0-ACP, with an apparent K(I)

56 duct containing the exosite was a hyperbolic mixed-type inhibitor of ADAMTS13 proteolysis of either V

57 ATP is a mixed-type inhibitor of cGMP production for both sGC and

58 We also found verapamil to be a partial mixed-type inhibitor of chloroquine transport via PfCRT,

59 It is a mixed-type inhibitor of ETC with the kinetic constants,

60 vealed that A-183 was a partial (hyperbolic) mixed-type inhibitor of FX activation having a Ki of 200

61 containing tetrahedral mimic is a reversible mixed-type inhibitor of Gsp synthetase with an inhibitio

62 H2O2 is a mixed-type inhibitor of the dioxygenase activity, sugges

63 HX1 was a mixed-type inhibitor of the halogenation activity of MPO

64 o be an uncompetitive inhibitor to CoA and a mixed-type inhibitor to ATP and OSB with low micromolar

65 FAD behaved as a mixed-type inhibitor with respect to NADPH.

66 ith arachidonic acid indicated that it was a mixed-type inhibitor.

67 wave power levels (500, 1000 and 1500 W) are mixed type inhibitors of polyphenoloxidase enzyme, showi

68 show at least one charge cluster, mostly of mixed type involving about equally anionic and cationic

69 Primary surveillance of mixed-type IPMN may be a reasonable strategy in select p

70 ents with MPD involvement, 238 patients with mixed-type IPMN, and 82 patients with main-duct IPMN alo

71 t primary surveillance, 70 for MPD-involved, mixed-type IPMN.

72 nal consensus that main-duct (MD) as well as mixed-type IPMNs should be treated surgically due to a h

73 mong invasive IPMNs, the majority (58%) were mixed-type lesions according to preoperative imaging.

74 MNs are misclassified as BD-IPMNs but reveal mixed-type lesions in histopathology.

75 DL is defined by the presence of >/=10 mixed-type lesions such as inflammatory papules and ulce

76 tumors, which included solid, papillary, and mixed types, may be associated with the cellular origin

77 activity of topoisomerase II by an unusual, mixed-type mechanism; the drug is not a competitive inhi

78 centrally to form a large BB (n = 5), and a mixed type (n = 3).

79 h dGTP, dGMP, whereas dTDP appears to have a mixed type of inhibition of dTMP kinase.

80 rans-anethole demonstrated noncompetitive to mixed type of inhibition of lens aldose reductase using

81 under varied PRPP and saturated pABA, and a mixed type of inhibition, K(1) = 0.60 mm and K(2) = 1.90

82 under varied PRPP and saturated pABA, and a mixed type of inhibition, K(1) = 1.40 mm and K = 3.800 m

83 However, PAR1-P40A displayed a mixed type of inhibition.

84 Small series, studies reporting on mixed types of cholangiocarcinoma, or exclusively on hep

85 e new method is also applicable to data with mixed types of markers (dominant and codominant) with un

86 h consumed skim milk, and one-tenth consumed mixed types of milk.

87 methods are general: they can be applied to mixed types of traits, and to Z-statistics or P-values a

88 zymes AGAO and PPLO, pure noncompetitive and mixed-type/partially competitive inhibition is observed.

89 Azide was found to exhibit mixed-type/partially competitive inhibition with respect

90 er, EagleView supports viewing coassembly of mixed-type reads from different technologies and support

91 pid vesicles, characteristic of a hyperbolic mixed-type reversible inhibitor.

92 The complexes also serve as mixed-type reversible inhibitors of human AChE and BuChE

93 was 5.8 % (95 % CI: 4.14, 7.53) (43/737) and mixed type VKC was the most frequent form which was foun

94 d invasive adenocarcinoma and adenocarcinoma-mixed type with BAC features identified transcriptional

95 studies have shown that the inhibition is of mixed type with prominent (ca. 60 % of inhibition) uncom

96 6 microM and that H(2)O(2) inhibition is of mixed-type with respect to O(2).